C. Dye

C. Dye, S. Ottmani, L. Laasri, 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Spatial analysis of tuberculosis cases in migrants and permanent residents, Beijing, 2000-2006.

C. Dye, W. Cao, Wen-Yi Zhang, 2008, Emerging infectious diseases.

Lessons learnt from implementation of the International Health Regulations: a systematic review

C. Dye, A. Suthar, Jason M. Nagata, 2017, Bulletin of the World Health Organization.

The Population Dynamics and Control of Tuberculosis

C. Dye, B. Williams, B. Williams, 2010, Science.

Modelling challenges in context: lessons from malaria, HIV, and tuberculosis.

L. Childs, C. Dye, C. Buckee, 2015, Epidemics.

The potential impact of new diagnostic tests on tuberculosis epidemics

C. Dye, 2012, The Indian journal of medical research.

Detection and treatment of subclinical tuberculosis.

Gerhard Walzl, Stefan H E Kaufmann, Thomas Dick, 2012, Tuberculosis.

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

Christopher Dye, C. Dye, B. Williams, 2009, The Lancet.

Population dynamics of mosquito-borne disease: effects of flies which bite some people more frequently than others.

C. Dye, G. Hasibeder, C Dye, 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism

Christopher Dye, Lorna J. Kennedy, Annette Barnes, 2003, Immunogenetics.

Zika Virus as a Cause of Neurologic Disorders.

Christopher Dye, Nicola Low, N. Low, 2016, The New England journal of medicine.

Multigenic drug resistance among inbred malaria parasites

B G Williams, C. Dye, Brett Williams, 1997, Proceedings of the Royal Society of London. Series B: Biological Sciences.

Vectorial capacity: must we measure all its components?

C. Dye, 1986, Parasitology today.

Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list' [Review article].

T Cohen, C. Dye, D. Dowdy, 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

The resurgence of tuberculosis in Russia.

C. Dye, M. Shilova, 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Did we reach the 2005 targets for tuberculosis control?

C. Dye, M. Hosseini, C. Watt, 2007, Bulletin of the World Health Organization.

Tuberculosis

C. Dye, A. Harries, 2006 .

Rational 'DOTS plus' for the control of MDR-TB.

C. Dye, M. Espinal, M. Raviglione, 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Tuberculosis

T. Frieden, C. Dye, T. Sterling, 1925, The Lancet.

Serological and demographic evidence for domestic dogs as a source of canine distemper virus infection for Serengeti wildlife.

C. Dye, S. Cleaveland, C. Chillingworth, 2000, Veterinary microbiology.

Zero infection

C. Dye, P. Drury, Mark W. Woolhouse, 2014, Science.

The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru.

C. Dye, M. Espinal, P. Suarez, 2001, The Journal of infectious diseases.

An analysis of some factors determining the sporozoite rates, human blood indexes, and biting rates of members of the Anopheles punctulatus complex in Papua New Guinea.

T. Burkot, C. Dye, P. Graves, 1989, The American journal of tropical medicine and hygiene.

Early evaluation of transmission control measures in response to the 2019 novel coronavirus outbreak in China

Quanyi Wang, Yimeng Song, Christopher Dye, 2020 .

The effect of human mobility and control measures on the COVID-19 epidemic in China

Nuno R. Faria, A. Vespignani, D. Pigott, 2020, medRxiv.

Tissue cytokine responses in canine visceral leishmaniasis.

C. Dye, P. Kaye, O. Courtenay, 2001, The Journal of infectious diseases.

The analysis of parasite transmission by bloodsucking insects.

C. Dye, 1992, Annual review of entomology.

The life expectancy of phlebotomine sandflies: first field estimates from southern France

C. Dye, T. Wilkes, D. Elkins, 1987, Medical and veterinary entomology.

Pheromones, kairomones and the aggregation dynamics of the sandfly Lutzomyia longipalpis

C. Dye, D. Kelly, 1997, Animal Behaviour.

Low infectiousness of a wildlife host of Leishmania infantum: the crab-eating fox is not important for transmission

C. Dye, O. Courtenay, R. Quinnell, 2002, Parasitology.

Global burden of tuberculosis

Christopher Dye, Vikram Pathania, C. Dye, 1999 .

New methods for estimating the tuberculosis case detection rate in high-HIV prevalence countries: the example of Kenya.

C. Dye, K. Floyd, B. Williams, 2009, Bulletin of the World Health Organization.

Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases

Justin M. Cohen, R. Peeling, M. Tanner, 2017 .

The scale and dynamics of COVID-19 epidemics across Europe

C. Dye, J. Dagpunar, B. Williams, 2020, Royal Society Open Science.

Diabetes and the risk of tuberculosis: a neglected threat to public health?

G. Roglić, C. Dye, J. Critchley, 2007, Chronic illness.

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.

Christopher Dye, Dermot Maher, Neff Walker, 2003, Archives of internal medicine.

1 Global Epidemiology and Control of Tuberculosis

C. Dye, M. Borgdorff, 2007 .

Diagnostic preparedness for infectious disease outbreaks

M. Perkins, C. Dye, Marcel Tanner, 2017, The Lancet.

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

C. Dye, K. Floyd, C. Bonilla, 2002, The Lancet.

Anti-tuberculosis Drug Resistance in the World: Report no. 2: Prevalence and Trends

C. Dye, L. Simonsen, N. Binkin, 2000 .

Bird-parasite interactions: Ecology, evolution and behaviour

C. Dye, 1991 .

Ecology of Infectious Diseases in Natural Populations: Nonlinearities in the Dynamics of Indirectly-Transmitted Infections (or, does having a Vector make a Difference?)

C. Dye, B. Williams, 1995 .

Tuberculosis prevalence surveys: rationale and cost.

T. Holtz, C. Dye, F. Cobelens, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Accelerating progress towards tuberculosis elimination: the need for combination treatment and prevention.

Richard G. White, C. Dye, E. Vynnycky, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

COVID-19 herd immunity in the Brazilian Amazon

Marcio K. Oikawa, Nuno R. Faria, M. Kraemer, 2020, medRxiv.

Epidemiology of Ebola Virus Disease in the Western Area Region of Sierra Leone, 2014–2015

D. Kargbo, P. Formenty, C. Dye, 2017, Front. Public Health.

Data Needs for Evidence-Based Decisions: A TB Modeler’s “Wish List”

C. Dye, D. Dowdy, T. Cohen, 2014 .

Reducing the global burden of tuberculosis: the contribution of improved diagnostics

Federico Girosi, Christopher Dye, Emmett Keeler, 2006, Nature.

Reducing the Global Burden of Tuberculosis

Julia E. Aledort, F. Girosi, E. Keeler, 2006 .

Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection.

N. Nagelkerke, C. Dye, M. Borgdorff, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Global burden of disease

C. Dye, P. Nunn, A. Kochi, 1997, The Lancet.

Optimal Localization by Pointing Off Axis

Margaret L. Brandeau, Richard A. Olshen, Charles J. Stone, 2010 .

Malaria-attributed death rates in India

C. Dye, R. Cibulskis, A. Gunasekar, 2011, The Lancet.

From suspect to patient: tuberculosis diagnosis and treatment initiation in health facilities in South Africa.

C. Dye, E. Botha, N. Beyers, 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Economic Benefit of Tuberculosis Control

C. Dye, E. Klein, K. Floyd, 2007 .

The SARS Wake-Up Call

C. Dye, I. Nuttall, 2013, Science.

Competition amongst larval Aedes aegypti: the role of interference

C. Dye, 1984 .

New Insights into Platyhelminth Systematics and Evolution

C. Dye, P. Olliaro, J. Goding, 2000 .

Ebola Virus Infection Associated with Transmission from Survivors

C. Dye, T. Nyenswah, E. Hamblion, 2019, Emerging infectious diseases.

Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project.

C. Dye, M. Raviglione, E. Netto, 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers.

C. Dye, M. Hatherill, T. Scriba, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tuberculosis control in the era of HIV

C. Dye, K. Floyd, B. Williams, 2005, Nature Reviews Immunology.

Temperatures Without Fevers?

C. Dye, P. Reiter, 2000, Science.

Replication, differentiation, growth and the virulence of Trypanosoma brucei infections

C. Dye, N. Aslam, C. Turner, 1995, Parasitology.

Three-fold reduction in the prevalence of tuberculosis over 25 years in Indonesia.

C. Dye, D. Manissero, S. Soemantri, 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Maximum likelihood for parasitologists.

C. Dye, B. Williams, Christopher Dye, 1994, Parasitology today.

Practical preventive therapy for tuberculosis?

C. Dye, 2011, The New England journal of medicine.

What is the limit to case detection under the DOTS strategy for tuberculosis control?

Christopher Dye, C. Dye, B. Williams, 2003, Tuberculosis.

Tuberculosis: the role of risk factors and social determinants.

C. Dye, B. Williams, M. Raviglione, 2010 .

The epidemiology of canine visceral leishmaniasis in southern France: classical theory offers another explanation of the data

C. Dye, 1988, Parasitology.

Planning to improve global health: the next decade of tuberculosis control.

C. Dye, K. Floyd, J. Cunningham, 2007, Bulletin of the World Health Organization.

From MDGs to SDGs: New Impetus to Advance Health in Iran

N. K. Mohammadi, N. Jahanmehr, C. Dye, 2019, Health Scope.

Dynamics and Control of Infections on Networks

C. Dye, B. Williams, 2014 .

Universal voluntary HIV testing and immediate antiretroviral therapy – Authors' reply

C. Dye, B. Williams, R. Granich, 2009, The Lancet.

Mass treatment to eliminate tuberculosis from an island population.

C. Dye, A. Harries, R. Zachariah, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Predicting SARS-CoV-2 Variant Spread in a Completely Seropositive Population Using Semi-Quantitative Antibody Measurements in Blood Donors

Marcio K. Oikawa, Nuno R. Faria, C. Whittaker, 2022, medRxiv.

Monitoring mosquito net coverage for malaria control in Africa: possession vs. use by children under 5 years

John M. Miller, C. Dye, D. Alnwick, 2003, Tropical medicine & international health : TM & IH.

Tuberculosis 2000-2010: control, but not elimination.

C. Dye, 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Antiretroviral therapy is the principal cause of tuberculosis decline in southern and eastern Africa

C. Dye, B. Williams, 2018 .

After Ebola in West Africa--Unpredictable Risks, Preventable Epidemics.

Wes Hinsley, Stéphane Hugonnet, Thibaut Jombart, 2016, The New England journal of medicine.

The measurement and estimation of tuberculosis mortality.

C. Dye, Brett Williams, B. Williams, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

West African Ebola epidemic after one year--slowing but not yet under control.

Wes Hinsley, Stéphane Hugonnet, Thibaut Jombart, 2015, The New England journal of medicine.

The Burden of Drug‐Resistant Tuberculosis and Mechanisms for Its Control

Rajesh K. Gupta, C. Dye, M. Espinal, 2001, Annals of the New York Academy of Sciences.

Population genetics of nonclonal, nonrandomly mating malaria parasites.

C. Dye, 1991, Parasitology today.

Comparison of vaccination strategies for the control of dog rabies in Machakos District, Kenya

C. Dye, J. McDermott, P. Coleman, 2002, Epidemiology and Infection.

When are parasites clonal?

C. Dye, C. Davies, J. Lines, 1990, Nature.

Cutaneous leishmaniasis in the Peruvian Andes: factors associated with variability in clinical symptoms, response to treatment, and parasite isolation rate.

C. Dye, C. Davies, S. Sharp, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A cost-benefit analysis of BCG revaccination in the Czech Republic.

C. Dye, V. Pathania, L. Trnka, 1999, Vaccine.

The Potential Impact of Male Circumcision on HIV in Sub-Saharan Africa

James O Lloyd-Smith, Wayne M Getz, Christopher Dye, 2006, PLoS medicine.

Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis

R. Chaisson, C. Dye, S. Lawn, 2012, PLoS medicine.

Immunization coverage required to prevent outbreaks of dog rabies.

C. Dye, P. Coleman, 1996, Vaccine.

Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission.

C. Dye, J. Shaw, O. Courtenay, 2002, The Journal of infectious diseases.

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.

C. Dye, V. Pathania, M. Raviglione, 1999, JAMA.

After 2015: infectious diseases in a new era of health and development

Christopher Dye, C. Dye, 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

M. Suchard, N. Loman, M. Kraemer, 2021, Science.

Infectious diseases of humans: Dynamics and control: by R.M. Anderson and R.M. May, Oxford University Press, 1991. £50.00 hbk (viii + 757 pages) ISBN 0 19 854 5991

C. Dye, 1991 .

Detection of Leishmania infantum by PCR, serology and cellular immune response in a cohort study of Brazilian dogs

C. Dye, J. Shaw, O. Courtenay, 2001, Parasitology.

Global incidence of multidrug-resistant tuberculosis.

Mehran Hosseini, Brian G. Williams, Christopher Dye, 2006, The Journal of infectious diseases.

Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic

Marcio K. Oikawa, M. Kraemer, O. Pybus, 2020, Science.

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

Christopher Dye, Lone Simonsen, C. Dye, 2001, The New England journal of medicine.

Anti-tuberculosis drug resistance in the world: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 1997. 228pp. Price Sw. fr 25/US$22.50 (in developing countries Sw. fir 17.50). (Reference WHO/TB/97.229)

C. Dye, M. Aziz, B. Williams, 1998 .

Serological diagnosis of leishmaniasis: on detecting infection as well as disease

C. Dye, J. Dereure, E. Vidor, 1993, Epidemiology and Infection.

IgG subclass responses in a longitudinal study of canine visceral leishmaniasis.

C. Dye, P. Kaye, O. Courtenay, 2003, Veterinary immunology and immunopathology.

Epidemiological significance of vector–parasite interactions

C. Dye, 1990, Parasitology.

Falciparum malaria and climate change in the northwest frontier province of Pakistan.

M. Bouma, C. Dye, M J Bouma, 1996, The American journal of tropical medicine and hygiene.

Zoonotic cutaneous leishmaniasis in Saudi Arabia: results of a preliminary epidemiological survey in Al-Ahsa oasis.

C. Dye, R. Killick-Kendrick, R. Ben Ismail, 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

The epidemiology of canine leishmaniasis: transmission rates estimated from a cohort study in Amazonian Brazil

C. Dye, O. Courtenay, R. Quinnell, 1997, Parasitology.

Epidemiology of canine leishmaniasis: a comparative serological study of dogs and foxes in Amazon Brazil

D. Macdonald, C. Dye, J. Shaw, 1994, Parasitology.

Intra and inter-specific microsatellite variation in the Leishmania subgenus Viannia.

R. Russell, J. Blackwell, J. Ajioka, 1999, Molecular and biochemical parasitology.

Estimates of world-wide distribution of child deaths from acute respiratory infections.

C. Dye, J. Bryce, E. Gouws, 2002, The Lancet. Infectious diseases.

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

C. Dye, P. Fine, B. B. Trunz, 2006, The Lancet.

Global disparities in SARS-CoV-2 genomic surveillance

Nuno R. Faria, M. Suchard, S. Flaxman, 2021, medRxiv.

Exploratory Analysis of the Association between New-Type Drug Use and Sexual Transmission of HIV in China

C. Dye, Y. Bao, Wei Wang, 2010, The American journal of drug and alcohol abuse.

Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners.

R. Hayes, C. Dye, S. Charalambous, 2004, American journal of respiratory and critical care medicine.

Malnutrition, age and the risk of parasitic disease: visceral leishmaniasis revisited

C. Dye, B. Williams, 1993, Proceedings of the Royal Society of London. Series B: Biological Sciences.

Measuring tuberculosis burden, trends, and the impact of control programmes.

B G Williams, H L Rieder, C. Dye, 2008, The Lancet. Infectious diseases.

Communication among phlebotomine sandflies: a field study of domesticated Lutzomyia longipalpis populations in Amazonian Brazil

C. Dye, C. Davies, R. Lainson, 1991, Animal Behaviour.

Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis

Christopher Dye, C. Dye, 2009, Nature Reviews Microbiology.

The Development and Impact of Tuberculosis Vaccines

C. Dye, D. Young, 2006, Cell.

Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics

M Elizabeth Halloran, Christopher Dye, Ira M Longini, 2009, Proceedings of the National Academy of Sciences.

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration.

C. Dye, K. Castro, K. D. de Cock, 2006, The Lancet. Infectious diseases.

Alcohol use as a risk factor for tuberculosis – a systematic review

C. Dye, B. Williams, E. Jaramillo, 2008, BMC public health.

Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy.

R. Snow, C. Dye, E. Gouws, 2003, The Lancet. Infectious diseases.

Xpert MTB/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB/RIF.

Christopher Dye, Edina Sinanovic, Anna Vassall, 2015, The Lancet. Global health.

Heterogeneities in the transmission of infectious agents: implications for the design of control programs.

C. Dye, R. Anderson, J. Charlwood, 1997, Proceedings of the National Academy of Sciences of the United States of America.

WHO and the future of disease control programmes

Christopher Dye, Hiroki Nakatani, C. Dye, 2013, The Lancet.

Worldwide incidence of multidrug-resistant tuberculosis.

C. Dye, B. Williams, M. Espinal, 2002, The Journal of infectious diseases.

The logic of visceral leishmaniasis control.

C. Dye, C Dye, 1996, The American journal of tropical medicine and hygiene.

Earthquakes, influenza and cycles of Indian kala-azar.

D M Wolpert, D. Wolpert, C. Dye, 1988, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Differential application of lambda‐cyhalothrin to control the sandfly Lutzomyia longipalpis

C. Dye, Z. Mustafa, D. Kelly, 1997, Medical and veterinary entomology.

Why Measure the Vectorial Capacity of Sandflies

C. Dye, 1989 .

An experimental study of the peridomestic distribution of Lutzomyia longipalpis (Diptera: Psychodidae)

C. Dye, R. Quinnell, 1994 .

Correlates of the peridomestic abundance of Lutzomyia longipalpis (Diptera: Psychodidae) in Amazonian Brazil

C. Dye, R. Quinnell, 1994, Medical and veterinary entomology.

Host preferences of the phlebotomine sandfly Lutzomyia longipalpis in Amazonian Brazil

C. Dye, R. Quinnell, J. Shaw, 1992, Medical and veterinary entomology.

Leishmaniasis epidemiology: the theory catches up

C. Dye, C Dye, Christopher Dye, 1992, Parasitology.

Cutaneous leishmaniasis in the Peruvian Andes: risk factors identified from a village cohort study.

C. Dye, C. Davies, E. A. Llanos-Cuentas, 1997, The American journal of tropical medicine and hygiene.

Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity

C. Dye, C. Davies, E. A. Llanos-Cuentas, 1995, Epidemiology and Infection.

Amazonian visceral leishmaniasis--distribution of the vector Lutzomyia longipalpis (Lutz & Neiva) in relation to the fox Cerdocyon thous (linn.) and the efficiency of this reservoir host as a source of infection.

D. Macdonald, C. Dye, J. Shaw, 1990, Memorias do Instituto Oswaldo Cruz.

The fall and rise of Andean cutaneous leishmaniasis: transient impact of the DDT campaign in Peru.

C. Dye, C. Davies, E. Tolentino, 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Are nulliparous sandflies light-shy?

C. Dye, P. Gibb, T. Anderson, 1988, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Highly active antiretroviral treatment for the prevention of HIV transmission

C. Dye, C. Gilks, K. D. de Cock, 2010, Journal of the International AIDS Society.

HIV burden in men who have sex with men: a prospective cohort study 2007–2012

Wei Li, J. Salomon, C. Dye, 2015, Scientific Reports.

Measuring the capacity of blackflies as vectors of onchocerciasis: Simulium damnosum S.L. in southwest Sudan

C. Dye, R. Baker, 1986 .

Zika Virus and the Guillain-Barré Syndrome - Case Series from Seven Countries.

Christopher Dye, Roberto Badaró, C. Dye, 2016, The New England journal of medicine.

Worldwide Incidence of Malaria in 2009: Estimates, Time Trends, and a Critique of Methods

C. Dye, R. Cibulskis, Maru Aregawi, 2011, PLoS medicine.

Cycles of malaria associated with El Niño in Venezuela.

M. Bouma, C. Dye, M J Bouma, 1997, JAMA.

Evidence for a long-term increase in the incidence of Leishmania tropica in Aleppo, Syria.

C. Dye, R. Ashford, J. Rioux, 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Approaches to vector control: new and trusted. 5. The epidemiological context of vector control.

C. Dye, Christopher Dye, 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Does facilitation imply a threshold for the eradication of lymphatic filariasis?

C. Dye, Christopher Dye, 1992, Parasitology today.

Models for the population dynamics of the yellow fever mosquito, Aedes aegypti

Christopher Dye, C. Dye, 1984 .

Ebola vaccine--an urgent international priority.

Christopher Dye, C. Dye, M. Kieny, 2014, The New England journal of medicine.

Data sharing in public health emergencies: a call to researchers

Christopher Dye, Kidist Bartolomeos, Marie Paule Kieny, 2016, Bulletin of the World Health Organization.

Ebola virus disease in the Democratic Republic of Congo.

Christopher Dye, Licé González-Angulo, P. Formenty, 2014, The New England journal of medicine.

Spatial Analysis of Tuberculosis Cases in Migrants and Permanent Residents, Beijing, 2000–2006

C. Dye, W. Cao, Wen-Yi Zhang, 2008, Emerging Infectious Diseases.

Maintenance of a microparasite infecting several host species: rabies in the Serengeti

C. Dye, S. Cleaveland, Christopher Dye, 1995, Parasitology.

Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007

C. Dye, B. Nahlen, J. Garcia-Calleja, 2010, BMC infectious diseases.

Cost effectiveness analysis of strategies for tuberculosis control in developing countries

R. Baltussen, C. Dye, K. Floyd, 2005, BMJ : British Medical Journal.

Assessment of worldwide tuberculosis control

Christopher Dye, Arata Kochi, C. Dye, 1997, The Lancet.

Antiretroviral Drugs for Tuberculosis Control in the Era of HIV/AIDS

Brian G. Williams, Christopher Dye, C. Dye, 2003, Science.

Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China.

C. Dye, Brett Williams, S. Scheele, 2000, International journal of epidemiology.

Scale-free dynamics of COVID-19 in a Brazilian city

Nuno R. Faria, C. Dye, K. Parag, 2021, Applied Mathematical Modelling.

HIV Treatment as Prevention: Debate and Commentary—Will Early Infection Compromise Treatment-as-Prevention Strategies?

Brian G. Williams, Christopher Dye, Christophe Fraser, 2012, PLoS medicine.

Report 46: Factors driving extensive spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals

Nuno R. Faria, S. Bhatt, P. Lemey, 2021, medRxiv.

Health in financial crises: economic recession and tuberculosis in Central and Eastern Europe

N. Arinaminpathy, C. Dye, 2010, Journal of The Royal Society Interface.

Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study

C. Dye, L. Asencios, R. Gilman, 2015, PLoS medicine.

Controlling the Last Known Cluster of Ebola Virus Disease — Liberia, January–February 2015

Christopher Dye, Tolbert Nyenswah, Thomas R. Navin, 2015, MMWR. Morbidity and mortality weekly report.

Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'.

T Cohen, C. Dye, D. Dowdy, 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations.

C. Dye, G. Schmid, E. Gouws, 2006, The Journal of infectious diseases.

Clinical Prognostic Value of RNA Viral Load and CD4 Cell Counts during Untreated HIV-1 Infection—A Quantitative Review

Brian G. Williams, Christopher Dye, C. Dye, 2009, PLoS ONE.

Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil

Marcio K. Oikawa, Nuno R. Faria, C. Whittaker, 2022, BMC Infectious Diseases.

Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study

Nuno R. Faria, O. Pybus, M. Diamond, 2021, The Lancet Microbe.

Reinfection by the SARS-CoV-2 P.1 variant in blood donors in Manaus, Brazil

Marcio K. Oikawa, Nuno R. Faria, C. Dye, 2021, medRxiv.

Ebola Virus Disease among Male and Female Persons in West Africa.

Wes Hinsley, Thibaut Jombart, Gemma Nedjati-Gilani, 2016, The New England journal of medicine.

Modeling the impact of immigration on the epidemiology of tuberculosis.

Dan Feng, Gong-You Tang, Zhen Jin, 2008, Theoretical population biology.

The international Ebola emergency.

Christopher Dye, P. Formenty, C. Dye, 2014, The New England journal of medicine.

Perspective: Weigh all TB risks

C. Dye, M. Raviglione, 2013, Nature.

Creating a global observatory for health R&D

Christopher Dye, C. Dye, R. Terry, 2014, Science.

Epidemiology of canine leishmaniasis: prevalence, incidence and basic reproduction number calculated from a cross-sectional serological survey on the island of Gozo, Malta

C. Dye, R. Killick-Kendrick, G. Hasibeder, 1992, Parasitology.

Drivers of tuberculosis epidemics: the role of risk factors and social determinants.

C. Dye, B. Williams, M. Raviglione, 2009, Social science & medicine.

Reply to Lawn and Wood

C. Dye, G. Schmid, E. Gouws, 2007 .

THE WORLD BANK ECSHD THE TB AND HIV/AIDS EPIDEMICS

N. Nagelkerke, C. Dye, J. Godinho, 2002 .

The TB and HIV/AIDS epidemics in the Russian Federation

N. Nagelkerke, C. Dye, J. Godinho, 2001 .

H L Rieder, C. Dye, L. Simonsen, 2001, The New England journal of medicine.

Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis

Brian G. Williams, Christopher Dye, C. Dye, 2002, Science.

The impact of HIV/AIDS on the control of tuberculosis in India.

B G Williams, L S Chauhan, C. Dye, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Global Epidemiology and Control of Tuberculosis

C. Dye, M. Borgdorff, 2017 .

The decline of tuberculosis in Yemen: evaluation based on two nationwide tuberculin surveys.

C. Dye, B. Williams, A. Seita, 2009, The International Journal of Tuberculosis and Lung Disease.

A consistent log-linear relationship between tuberculosis incidence and body mass index.

C. Dye, P. Cegielski, B. Williams, 2010, International journal of epidemiology.

Dynamics and control of the global tuberculosis epidemic

C. Dye, M. Raviglione, M C Raviglione, 2000, Current opinion in pulmonary medicine.

Criteria for the control of drug-resistant tuberculosis.

B G Williams, C. Dye, Brett Williams, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally.

Christopher Dye, S Mehran Hosseini, C. Dye, 2005, JAMA.

Can DOTS control multidrug-resistant tuberculosis?

C. Dye, M. Espinal, 2005, The Lancet.

A National Tuberculosis Archive

C. Dye, P. Small, P. Farmer, 2006, Science.

Prospects for worldwide tuberculosis control under the WHO DOTS strategy

Christopher Dye, C. Dye, B. Williams, 1998, The Lancet.

Trends in tuberculosis incidence and their determinants in 134 countries.

C. Dye, Brett Williams, B. Williams, 2009, Bulletin of the World Health Organization.

Extensive polymorphism at the Gp63 locus in field isolates of Leishmania peruviana.

J. Blackwell, J. Ajioka, C. Dye, 1995, Molecular and biochemical parasitology.

Slow Elimination of Multidrug-Resistant Tuberculosis

C. Dye, B. Williams, B. Williams, 2009, Science Translational Medicine.

Intraspecific competition amongst larval Aedes aegypti: food exploitation or chemical interference?

C. Dye, 1982 .

Asymptomatic SARS-CoV-2 infection and the demography of COVID-19

J. Brownstein, O. Bjørnstad, C. Dye, 2021, medRxiv.

Density-dependent feeding success in a field population of the sandfly, Lutzomyia longipalpis

C. Dye, D. Kelly, Z. Mustafa, 1996 .

Antiretroviral therapy for tuberculosis control in nine African countries

C. Dye, P. Glaziou, Brett Williams, 2010, Proceedings of the National Academy of Sciences.

Malaria Infection Rate of Amazonian Primates Increases with Body Weight and Group Size

C. Dye, L. Deane, J. Ayres, 1991 .

Health and Urban Living

Christopher Dye, C. Dye, 2008, Science.

Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence

C. Dye, K. Floyd, B. Williams, 2005, BMC public health.

Tuberculosis control in China: use of modelling to develop targets and policies

C. Dye, D. Chin, Hsien-Ho Lin, 2015, Bulletin of the World Health Organization.

SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals

Marcio K. Oikawa, Nuno R. Faria, C. Whittaker, 2022 .

COVID-19 vaccination passports

C. Dye, M. Mills, 2021, Science.

Mathematical models of the epidemiology and control of drug-resistant TB

Christopher Dye, Ted Cohen, Caroline Colijn, 2009, Expert review of respiratory medicine.

Prospects for tuberculosis elimination.

C. Dye, K. Floyd, P. Glaziou, 2013, Annual review of public health.

Dynamics and control of infections on social networks of population types.

C. Dye, B. Williams, 2017, Epidemics.

Dynamics and Control of Infections on Social Networks of Population Types

C. Dye, B. Williams, 2017, bioRxiv.

Dynamics and Control of Infections on Social Networks

C. Dye, B. Williams, 2014, 1410.8499.

Modelling COVID-19

James O. Lloyd-Smith, Munik Shrestha, Rosalind M Eggo, 2020, Nature Reviews Physics.

Tuberculosis epidemics driven by HIV: is prevention better than cure?

Christopher Dye, C. Dye, B. Williams, 2003, AIDS.

Risk of COVID-19 and long-term exposure to air pollution: evidence from the first wave in China

N. Stenseth, M. Kraemer, Chieh-Hsi Wu, 2020 .

Risk of COVID-19 is associated with long-term exposure to air pollution

N. Stenseth, M. Kraemer, H. Tian, 2020, medRxiv.

Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review.

C. Dye, B. Williams, P. Nunn, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

India's leading role in tuberculosis epidemiology & control.

C. Dye, 2006, The Indian journal of medical research.

Evaluation of Immigrant Tuberculosis Screening in Industrialized Countries

C. Dye, A. Lalvani, M. Pareek, 2012, Emerging infectious diseases.

Eliminating human tuberculosis in the twenty-first century

Christopher Dye, C. Dye, B. Williams, 2008, Journal of The Royal Society Interface.

Biological and Statistical Heterogeneity in Malaria Transmission

C. Dye, B. Williams, 2011, 1105.2559.

Combining Domestic and Foreign Investment to Expand Tuberculosis Control in China

C. Dye, Wei Wang, Wei Chen, 2010, PLoS medicine.

Leishmaniasis: the first centenary (1885-1985) new strategies for control.

S. Croft, C. Dye, L. Kahl, 1988, Parasitology today.

The impact of new tuberculosis diagnostics on transmission: why context matters.

C. Dye, D. Dowdy, T. Cohen, 2012, Bulletin of the World Health Organization.

Zika Virus Infection and Associated Neurologic Disorders in Brazil.

C. Dye, Wanderson K. de Oliveira, G. Coelho, 2017, The New England journal of medicine.

Targets for global tuberculosis control.

C. Dye, D. Maher, M. Espinal, 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Directly observed therapy and treatment adherence

Dermot Maher, C. Dye, M. Uplekar, 2000, The Lancet.

Serengeti wild dogs: what really happened?

C. Dye, Christopher Dye, 1996, Trends in ecology & evolution.

Tuberculosis decline in populations affected by HIV: a retrospective study of 12 countries in the WHO African Region

C. Dye, B. Williams, B. Williams, 2019, Bulletin of the World Health Organization.

On sex ratio and inbreeding in malaria parasite populations.

C. Dye, H. Godfray, 1993, Journal of theoretical biology.

Drug-Resistant Tuberculosis in Zhejiang Province, China, 1999–2008

C. Dye, Z. Jia, Xiaomeng Wang, 2012, Emerging infectious diseases.

Calling on Europe to support operational research in low-income and middle-income countries.

C. Dye, A. Ramsay, A. Harries, 2014, The Lancet. Global health.

Drug resistant tuberculosis: biology, epidemiology and control

C. Dye, 2009 .

Measles vaccination policy

C. Dye, F. Cutts, B. Williams, 1995, Epidemiology and Infection.

Ebola virus disease in West Africa--the first 9 months.

C. Dye, 2015, The New England journal of medicine.

Making wider use of the world's most widely used vaccine: Bacille Calmette–Guérin revaccination reconsidered

C. Dye, 2013, Journal of The Royal Society Interface.

Expanded health systems for sustainable development

C. Dye, 2018, Science.

The rate of decline of CD4 T-cells in people infected with HIV

C. Dye, E. Gouws, B. Williams, 2009, 0908.1556.

Low access to a highly effective therapy: a challenge for international tuberculosis control.

Christopher Dye, C. Dye, Catherine J Watt, 2002, Bulletin of the World Health Organization.

Estimating the Global Health Impact of Improved Diagnostic Tools for the Developing World

Julia E. Aledort, F. Girosi, E. Keeler, 2007 .

How can mathematical models advance tuberculosis control in high HIV prevalence settings?

A. Vassall, C. Dye, P. Eckhoff, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Nutrition, Diabetes and Tuberculosis in the Epidemiological Transition

G. Roglić, C. Dye, B. Williams, 2011, PloS one.

Will tuberculosis become resistant to all antibiotics?

C. Dye, M. Espinal, C Dye, 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

Best practices for sharing information through data platforms: establishing the principles

Christopher Dye, Marie Paule Kieny, C. Dye, 2016, Bulletin of the World Health Organization.

Role of acute infection in HIV transmission

C. Dye, B. Williams, R. Granich, 2011, The Lancet.

Tuberculosis epidemics driven by HIV

Brian G. Williams, Christopher Dye, Christine S. M. Currie, 2003 .

How can the sustainable development goals improve global health? A call for papers

C. Dye, S. Acharya, 2017, Bulletin of the World Health Organization.

Population ecology of individuals (monographs in population biology 25): by Adam Łomnicki, Princeton University Press, 1988. £25.20 hbk, £7 90 pbk (x+223 pages) ISBN 0 691 08462 9

C. Dye, 1988 .

The Global Drug Facility as an intervention in the market for tuberculosis drugs

N. Arinaminpathy, C. Dye, Thierry Cordier-Lassalle, 2015, Bulletin of the World Health Organization.

The Potential Impact of Male Circumcision on HIV in Sub-Saharan Africa

W. Getz, C. Dye, J. Lloyd-Smith, 2006, PLoS medicine.

Tuberculosis 2000-2010: control, but not elimination [The Comstock Lecture].

C. Dye, 2000, The International Journal of Tuberculosis and Lung Disease.

A world of cities and the end of TB

A. Ross, C. Dye, A. Prasad, 2016, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Spatially targeted digital chest radiography to reduce tuberculosis in high-burden settings: A study of adaptive decision making

C. Dye, T. Cohen, R. Yaesoubi, 2022, Epidemics.

Sustaining a national tuberculosis control programme during civil crisis: 6 years of experience in Syria.

C. Dye, S. Baghdadi, Ghada Muhjazi, 2018, The Lancet Respiratory Medicine.

Global tuberculosis control: surveillance planning financing. WHO report 2008.

C. Dye, K. Floyd, M. Uplekar, 2008 .

Early evaluation of the Wuhan City travel restrictions in response to the 2019 novel coronavirus outbreak

Quanyi Wang, Yimeng Song, Christopher Dye, 2020 .

A booster for tuberculosis vaccines.

C. Dye, 2004, JAMA.

Tuberculosis control in China: use of modelling to develop targets and

C. Dye, D. Chin, Hui Zhang, 2015 .

A theory of malaria vaccination

C. Dye, G. Targett, 1994, Nature.

Epidemiology. Modeling the SARS epidemic.

C. Dye, N. Gay, Nigel Gay, 2003, Science.

A major event for new tuberculosis vaccines

C. Dye, P. Fine, 2013, The Lancet.

Ebola Virus Disease among Male and Female Persons in West Africa.

C. Fraser, C. Dye, I. Blake, 2016, The New England journal of medicine.

Controlling the Last Known Cluster of Ebola Virus Disease — Liberia, January–February 2015

Mosoka P. Fallah, F. Mahoney, C. Dye, 2015, MMWR. Morbidity and mortality weekly report.

The Global Drug Facility and its role in the market for tuberculosis drugs

N. Arinaminpathy, C. Dye, Thierry Cordier-Lassalle, 2013, The Lancet.

Modelling local and global effects on the risk of contracting Tuberculosis using stochastic Markov-chain models.

K A Hoad, A H van't Hoog, D Rosen, 2009, Mathematical biosciences.

Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review.

C. Dye, P. Nunn, E. Korenromp, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Population dynamics and control of multidrug-resistant tuberculosis

C. Dye, B. Williams, 2000 .

Mathematical modelling and theory for estimating the basic reproduction number of canine leishmaniasis

C. Dye, G. Hasibeder, J. Carpenter, 1992, Parasitology.

Tuberculosis deaths in countries with high HIV prevalence: what is their use as an indicator in tuberculosis programme monitoring and epidemiological surveillance?

C. Dye, D. Maher, M. Raviglione, 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Chapter 3 – The global epidemiology of tuberculosis

C. Dye, K. Lönnroth, C. Watt, 2009 .

Modeling infectious disease dynamics in the complex landscape of global health

V. Isham, C. Viboud, P. Klepac, 2015, Science.

Achieving the millennium development goals for health Cost effectiveness analysis of strategies for tuberculosis control in developing countries

C. Dye, K. Floyd, 2017 .

Financing tuberculosis control: the role of a global financial monitoring system.

C. Dye, K. Floyd, A. Pantoja, 2007, Bulletin of the World Health Organization.

Cost effectiveness analysis of strategies for tuberculosis control in developing countries

R. Baltussen, C. Dye, K. Floyd, 2005, BMJ : British Medical Journal.

Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence

C. Dye, K. Floyd, C. Currie, 2005, BMC public health.

Modeling the impact of immigration on the epidemiology of tuberculosis.

L. Fang, C. Dye, Zhen Jin, 2008, Theoretical population biology.

The SARS Wake-Up Call

C. Dye, I. Nuttall, 2013, Science.

Tuberculosis in European cities: establishment of a patient monitoring system over 10 years in Paris, France.

R. Porcher, C. Dye, D. Farge, 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.